AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vassiliki A Papadimitrakopoulou, MD
The University of Texas/M.D. Anderson Cancer Center, Houston, Tx, USA
Principal Investigator - Yilong Wu, MD
Guangdong General Hospital, Guangdong, 510030, China
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
150 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Darlinghurst, Australia
- Research Site
Heidelberg, Australia
- Research Site
Kogarah, Australia
- Research Site
Nedlands, Australia
- Research Site
Woolloongabba, Australia
- Research Site
Edmonton, Alberta, Canada
- Research Site
Vancouver, British Columbia, Canada
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
Ottawa, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Beijing, China
- Research Site
Beijing, China
- Research Site
Changchun, China
- Research Site
Chongqing, China
- Research Site
Chongqing, China
- Research Site
Fuzhou, China
- Research Site
Guangzhou, China
- Research Site
Guangzhou, China
- Research Site
Hangzhou, China
- Research Site
Harbin, China
- Research Site
Nanchang, China
- Research Site
Shanghai, China
- Research Site
Shanghai, China
- Research Site
Tianjin, China
- Research Site
Zhengzhou, China
- Research Site
Ürümqi, China
- Research Site
Clermont-Ferrand, France
- Research Site
Dijon, France
- Research Site
Lille, France
- Research Site
Marseille, France
- Research Site
Paris, France
- Research Site
Strasbourg, France
- Research Site
Toulouse, France
- Research Site
Villejuif, France
- Research Site
Essen, Germany
- Research Site
Frankfurt, Germany
- Research Site
Gerlingen, Germany
- Research Site
Oldenburg, Germany
- Research Site
Regensburg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Aug 2014
- Primary completion
- 15 Apr 2016
- Completion
- 15 Dec 2023
- Last update posted
- 7 Jan 2025
- Registered enrollment
- 421
- Registry id
- NCT02151981
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.